Search company, investor...

Cruzar Medsystems


Series B | Alive

Total Raised


Last Raised

$2.85M | 6 yrs ago

About Cruzar Medsystems

Cruzar Medical is a medical device company developing a radically new approach to the persistent challenge of crossing chronic total occlusions (CTO's) in central and peripheral blood vessels.

Headquarters Location

35 Braintree Hill Park Suite 301

Braintree, Massachusetts, 02184,

United States


Missing: Cruzar Medsystems's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Cruzar Medsystems's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Cruzar Medsystems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cruzar Medsystems is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,693 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

Cruzar Medsystems Patents

Cruzar Medsystems has filed 8 patents.

The 3 most popular patent topics include:

  • Cardiac arrhythmia
  • Anesthesia
  • Angiology
patents chart

Application Date

Grant Date


Related Topics




Vascular diseases, Interventional radiology, Implants (medicine), Heart diseases, Angiology


Application Date


Grant Date



Related Topics

Vascular diseases, Interventional radiology, Implants (medicine), Heart diseases, Angiology



Latest Cruzar Medsystems News

Greenberg Traurig's IP Group Congratulates Three Clients on 2020 BPLA Invented Here! Honor

Nov 18, 2020

Last updated Nov 17, 2020 BOSTON, Nov. 17, 2020 /PRNewswire-PRWeb/ — Greenberg Traurig, LLP’s Boston Intellectual Property & Technology (IP) Group congratulates three of its clients – Cruzar Medsystems, Inc., Philipp K. Lang, and the University of New England – for being honored with the 2020 Boston Patent Law Association (BPLA) Invented Here! award for their patented innovations. This is the seventh consecutive year that Greenberg Traurig’s Boston IP Group has had clients recognized by the BPLA Invented Here! Committee. Greenberg Traurig’s clients were selected for the following patents: “Catheter with vessel lining and methods for using same,” (U.S. Patent No. 10,441,755) assigned to Cruzar Medsystems, Inc.; represented by Chinh H. Pham. “Augmented reality guidance systems for superimposing virtual implant components onto the physical joint of a patient,” (U.S. Patent No. 10,368,947) assigned to Philipp K. Lang; represented by Barry Schindler and Natalie Salem, Ph.D. “Methods and Diagnostics for Cancer Detection and Treatment Monitoring,” (U.S. Patent No. 10,073,099) assigned to the University of New England; represented by …

Cruzar Medsystems Frequently Asked Questions (FAQ)

  • Where is Cruzar Medsystems's headquarters?

    Cruzar Medsystems's headquarters is located at 35 Braintree Hill Park, Braintree.

  • What is Cruzar Medsystems's latest funding round?

    Cruzar Medsystems's latest funding round is Series B.

  • How much did Cruzar Medsystems raise?

    Cruzar Medsystems raised a total of $3.9M.

  • Who are the investors of Cruzar Medsystems?

    Investors of Cruzar Medsystems include Catalyst Health Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.